Focusing onVIGILANCE & PREPAREDNESSDespite advances in development of countermeasures such as diagnostics, therapeutics and vaccines, world travel and increased global interdependence have added layers of complexity to containing infectious diseases. COVID-, an outcome of weaponisation by genetic manipulation as part of ‘gain of function’ research, had brought the entire world to its knees in le...
biospectrumasia.com was registered 2 decades 3 months ago. It has a alexa rank of #235,798 in the world. It is a domain having .com extension. It is estimated worth of $ 39,420.00 and have a daily income of around $ 73.00. As no active threats were reported recently, biospectrumasia.com is SAFE to browse.
Daily Unique Visitors: | 6,507 |
Daily Pageviews: | 26,028 |
Income Per Day: | $ 73.00 |
Estimated Worth: | $ 39,420.00 |
Google Indexed Pages: | Not Applicable |
Yahoo Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Google Backlinks: | Not Applicable |
Bing Backlinks: | Not Applicable |
Alexa BackLinks: | Not Applicable |
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: | Very Poor |
WOT Privacy: | Very Poor |
WOT Child Safety: | Very Poor |
Alexa Rank: | 235,798 |
PageSpeed Score: | 89 ON 100 |
Domain Authority: | 49 ON 100 |
Bounce Rate: | Not Applicable |
Time On Site: | Not Applicable |
Total Traffic: | 119.91K |
Direct Traffic: | 30.38% |
Referral Traffic: | 2.29% |
Search Traffic: | 63.73% |
Social Traffic: | 3.38% |
Mail Traffic: | 0.22% |
Display Traffic: | 0% |
BioSpectrum India & BioSpectrum Asia ... The world's first mobile #lung cancer screening facility to help boost early detection and increase #survival rates in ...
View BioSpectrum Asia (www.biospectrumasia.com) location in Central Singapore, Singapore , revenue, industry and description. Find related and similar ...
BioSpectrum Asia, started originally as a Business Life-Science industry magazine with an objective to create a platform for growing Asia-Pacific life sciences ...
Bio Spectrum Asia. BioSpectrum is an integrated B2B media platform for the healthcare and bioscience industry in the Asia Pacific region.
BioSpectrum Asia interview with Telix Japan President & COO Dr Shintaro Nishimura on the APAC oncology market & opportunities/challenges in the Japanese ...
1, http://www.biospectrumasia.com/biospectrum/news/221744/global-biosimilars-market-worth-usd55-bn-2020-gbi-research Monday August 3, 2015.
BioSpectrum Asia: Evidence-based medicine and digital health go mainstream. Jan 31, 2018. Digital health will be mainstream for most healthcare ...
May 28, 2021 ... URL of media report : https://www.biospectrumasia.com/news/98/18244/singapore-develops-new-biomaterial-to-aid-in-bone-repair.html.
In an interview with BioSpectrum Asia, Novotech CEO Dr John Moller provides his thoughts on the state of Australia's medical technologies, biotechn.
BioSpectrum Asia is a unique, integrated B2B media platform of print, digital, online and events. It engages its readers from Life-Sciences industry (Pharma ...
BioSpectrum is an integrated B2B media platform for the healthcare and bioscience industry in the Asia Pacific region.
Aug 11, 2020 ... Source: https://www.biospectrumasia.com/news/91/16457/australian-develops-effective-triple-therapy-to-treat-covid-19.html.
BioSpectrum Asia. FDA sets up SARS-CoV-2 reference panel for diagnostic tests. 2020 [cited 2020 Sep 15]. https://www.biospectrumasia.com/news/30/16018/fda- ...
Buy a digital subscription to BioSpectrum Asia with PressReader and enjoy unlimited reading on up to 5 devices. 7-day free trial.
Mar 13, 2020 ... Our chairman and Co-founder Dr. Latha Poonamallee sat down for an interview with BioSpectrum Asia March edition.
Dec 7, 2017 ... BioSpectrum is an integrated B2B media platform for the bioscience industry in the Asia Pacific region. It engages its readers from pharma, ...
Feb 17, 2016 ... Advertise in the BioSpectrum Asia magazine and reach key decision makers in pharma and healthcare. Contact Global Media Sales to find out ...
Varian reported a net income of $405 million during 2016 and the net profit margin was 12.5%. source: biospectrumasia.com. 10. Edwards Lifesciences Corporation.
Oct 21, 2021 ... DURHAM, N.C., October 21, 2021--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company using its ARCUS® genome ...
další zdroj: newagebd.net, biospectrumasia.com, arabnews.com · Primářka ARO: Ivermektin je bezpečný a zbavuje tělo viru. 23.2.2021_čas běží.
Nov 2, 2021 ... The partnership will leverage Metagenomi's novel gene editing technology and Moderna's mRNA platform, in addition to its lipid nanoparticle ...
BioSpectrum Asia. PromarkerD Predictive Diagnostics For DKD To Rollout In Asia. Recent Posts. November 2021 · October 2021 · September 2021 · August 2021 ...
H1 Headings: | Not Applicable | H2 Headings: | Not Applicable |
H3 Headings: | 1 | H4 Headings: | 17 |
H5 Headings: | 1 | H6 Headings: | Not Applicable |
Total IFRAMEs: | 1 | Total Images: | 37 |
Google Adsense: | Not Applicable | Google Analytics: | UA-58743002-1 |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
2021 News | 9 | 0.881 % | No |
October 2021 | 5 | 0.49 % | No |
November 2021 | 4 | 0.392 % | No |
December 2021 | 3 | 0.294 % | No |
Singapore develops | 3 | 0.294 % | No |
for the | 3 | 0.294 % | No |
02 November | 3 | 0.294 % | No |
New Zealand | 3 | 0.294 % | No |
first inhalable | 2 | 0.196 % | No |
world's first | 2 | 0.196 % | No |
bring world's | 2 | 0.196 % | No |
CanSinoBIO to | 2 | 0.196 % | No |
in elders | 2 | 0.196 % | No |
China’s CanSinoBIO | 2 | 0.196 % | No |
COVID19 vaccine | 2 | 0.196 % | No |
to bring | 2 | 0.196 % | No |
clinical and | 2 | 0.196 % | No |
testing offering | 2 | 0.196 % | No |
offering in | 2 | 0.196 % | No |
COVID19 testing | 2 | 0.196 % | No |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
02 November 2021 News | 3 | 0.294 % | No |
diabetes treatment in elders | 2 | 0.196 % | No |
for diabetes treatment in | 2 | 0.196 % | No |
China’s CanSinoBIO to bring | 2 | 0.196 % | No |
therapy for diabetes treatment | 2 | 0.196 % | No |
to bring world's first | 2 | 0.196 % | No |
first inhalable COVID19 vaccine | 2 | 0.196 % | No |
world's first inhalable COVID19 | 2 | 0.196 % | No |
closedloop therapy for diabetes | 2 | 0.196 % | No |
CanSinoBIO to bring world's | 2 | 0.196 % | No |
Australia uses closedloop therapy | 2 | 0.196 % | No |
world’s largest and highestresolution | 2 | 0.196 % | No |
largest and highestresolution atlas | 2 | 0.196 % | No |
and highestresolution atlas of | 2 | 0.196 % | No |
Singapore develops anticoagulant drugs | 2 | 0.196 % | No |
develops anticoagulant drugs from | 2 | 0.196 % | No |
Eurofins enhances clinical and | 2 | 0.196 % | No |
drugs from tick parasite | 2 | 0.196 % | No |
anticoagulant drugs from tick | 2 | 0.196 % | No |
uses closedloop therapy for | 2 | 0.196 % | No |
Domain Registrar: | Network Solutions, LLC |
---|---|
Registration Date: | 2004-08-09 2 decades 3 months 1 week ago |
Last Modified: | 2020-07-07 4 years 4 months 2 weeks ago |
Host | IP Address | Country | |
---|---|---|---|
ns31.worldnic.com | 162.159.26.212 | United States | |
ns32.worldnic.com | 162.159.27.146 | United States |
Host | Type | TTL | Extra |
---|---|---|---|
biospectrumasia.com | A | 3594 |
IP: 202.38.172.92 |
biospectrumasia.com | NS | 7200 |
Target: ns31.worldnic.com |
biospectrumasia.com | NS | 7200 |
Target: ns32.worldnic.com |
biospectrumasia.com | SOA | 7200 |
MNAME: NS31.WORLDNIC.com RNAME: namehost.WORLDNIC.com Serial: 121052006 Refresh: 10800 Retry: 3600 Expire: 604800 |
biospectrumasia.com | MX | 7200 |
Priority: 10 Target: alt3.aspmx.l.google.com |
biospectrumasia.com | MX | 7200 |
Priority: 5 Target: alt2.aspmx.l.google.com |
biospectrumasia.com | MX | 7200 |
Priority: 10 Target: alt4.aspmx.l.google.com |
biospectrumasia.com | MX | 7200 |
Priority: 5 Target: alt1.aspmx.l.google.com |
biospectrumasia.com | MX | 7200 |
Priority: 1 Target: aspmx.l.google.com |
biospectrumasia.com | TXT | 7200 |
TXT: google-site-verification=jSqZtucPcfJjt9G LlLJhApOtvKtu7J-8hVzupe40y10 |
biospectrumasia.com | TXT | 7200 |
TXT: google-site-verification=ZV5MJANlt8VUT9C CvUTiREdK36RyPkI7Wn5PLxb6kL0 |
biospectrumasia.com | TXT | 7200 |
TXT: google-site-verification=b6jmsUDwf7w_E_R gvmpYQtL-qdDWzHA65LI5rJ8mDsY |
1. | hanmi coldmask nasal spray |
2. | ai current research |
3. | healthcare platform malaysia |
4. | micare |
5. | icure acquires drug product approval for world’s first donepezil patch for treating dementia of the alzheimer type in korea |
Not Applicable |
1. | bionews.bioeconomycorporation.my |
2. | forums.hardwarezone.com.sg |
3. | en.wikipedia.org |
4. | ndrmedical.com |
1. | trackwebz.com |
2. | screening.purehealth.ae |
3. | store.globaldata.com |
4. | academic.oup.com |
The original Trawler Forum. Your 1 stop place for all things Trawler on the net. Discussions on economical power boats and cruisers.
over 68,976 images of more than 6,188 games. Detailed information for every pinball game made.